Modeling diseases in multiple mouse strains for precision medicine studies.
Andrés D KleinPublished in: Physiological genomics (2017)
The genetic basis of the phenotypic variability observed in patients can be studied in mice by generating disease models through genetic or chemical interventions in many genetic backgrounds where the clinical phenotypes can be assessed and used for genome-wide association studies (GWAS). This is particularly relevant for rare disorders, where patients sharing identical mutations can present with a wide variety of symptoms, but there are not enough number of patients to ensure statistical power of GWAS. Inbred strains are homozygous for each loci, and their single nucleotide polymorphisms catalogs are known and freely available, facilitating the bioinformatics and reducing the costs of the study, since it is not required to genotype every mouse. This kind of approach can be applied to pharmacogenomics studies as well.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- escherichia coli
- peritoneal dialysis
- type diabetes
- physical activity
- genome wide association
- patient reported outcomes
- dna methylation
- social media
- depressive symptoms
- skeletal muscle
- case control
- high fat diet induced
- genome wide association study